These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25172658)

  • 1. Snail regulates the motility of oral cancer cells via RhoA/Cdc42/p-ERM pathway.
    Li YY; Zhou CX; Gao Y
    Biochem Biophys Res Commun; 2014 Sep; 452(3):490-6. PubMed ID: 25172658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt5b promotes the cell motility essential for metastasis of oral squamous cell carcinoma through active Cdc42 and RhoA.
    Takeshita A; Iwai S; Morita Y; Niki-Yonekawa A; Hamada M; Yura Y
    Int J Oncol; 2014 Jan; 44(1):59-68. PubMed ID: 24220306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
    Zhang Z; Yang M; Chen R; Su W; Li P; Chen S; Chen Z; Chen A; Li S; Hu C
    Oncogene; 2014 Jun; 33(26):3374-82. PubMed ID: 23975422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated Vav2 modulates cellular invasion through Rac1 and Cdc42 in oral squamous cell carcinoma.
    Lai SY; Ziober AF; Lee MN; Cohen NA; Falls EM; Ziober BL
    Oral Oncol; 2008 Jul; 44(7):683-8. PubMed ID: 17996485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.
    Zuo Y; Wu Y; Chakraborty C
    J Cell Physiol; 2012 Apr; 227(4):1399-407. PubMed ID: 21618528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hhex inhibits cell migration via regulating RHOA/CDC42-CFL1 axis in human lung cancer cells.
    Li X; Ma G; Guo W; Mu N; Wang Y; Liu X; Su L
    Cell Commun Signal; 2021 Jul; 19(1):80. PubMed ID: 34321041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma.
    Tanabe K; Shinsato Y; Furukawa T; Kita Y; Hatanaka K; Minami K; Kawahara K; Yamamoto M; Baba K; Mori S; Uchikado Y; Maemura K; Tanimoto A; Natsugoe S
    Oncotarget; 2017 Jan; 8(4):6353-6363. PubMed ID: 28031525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vimentin-mediated regulation of cell motility through modulation of beta4 integrin protein levels in oral tumor derived cells.
    Dmello C; Sawant S; Alam H; Gangadaran P; Tiwari R; Dongre H; Rana N; Barve S; Costea DE; Chaukar D; Kane S; Pant H; Vaidya M
    Int J Biochem Cell Biol; 2016 Jan; 70():161-72. PubMed ID: 26646105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ubiquitin ligase RNF8 regulates Rho GTPases and promotes cytoskeletal changes and motility in triple-negative breast cancer cells.
    Pereira De Carvalho B; Chern YJ; He J; Chan CH
    FEBS Lett; 2021 Jan; 595(2):241-252. PubMed ID: 33205415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DEF6, a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA.
    Mavrakis KJ; McKinlay KJ; Jones P; Sablitzky F
    Exp Cell Res; 2004 Apr; 294(2):335-44. PubMed ID: 15023524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
    Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
    Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cdc42 downregulates MMP-1 expression by inhibiting the ERK1/2 pathway.
    Deroanne CF; Hamelryckx D; Ho TT; Lambert CA; Catroux P; Lapière CM; Nusgens BV
    J Cell Sci; 2005 Mar; 118(Pt 6):1173-83. PubMed ID: 15728253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells.
    Yamamura M; Noguchi K; Nakano Y; Segawa E; Zushi Y; Takaoka K; Kishimoto H; Hashimoto-Tamaoki T; Urade M
    Int J Oncol; 2013 Mar; 42(3):873-80. PubMed ID: 23292068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells.
    Wang SH; Chang JS; Hsiao JR; Yen YC; Jiang SS; Liu SH; Chen YL; Shen YY; Chang JY; Chen YW
    Oncogene; 2017 Mar; 36(11):1503-1515. PubMed ID: 27593938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA.
    Chang KW; Kao SY; Wu YH; Tsai MM; Tu HF; Liu CJ; Lui MT; Lin SC
    Oral Oncol; 2013 Jan; 49(1):27-33. PubMed ID: 22854067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression.
    Sun L; Diamond ME; Ottaviano AJ; Joseph MJ; Ananthanarayan V; Munshi HG
    Mol Cancer Res; 2008 Jan; 6(1):10-20. PubMed ID: 18234959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer.
    Zeng Y; Xie H; Qiao Y; Wang J; Zhu X; He G; Li Y; Ren X; Wang F; Liang L; Ding Y
    Cancer Sci; 2015 Oct; 106(10):1385-93. PubMed ID: 26258642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
    Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F
    Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro.
    Schlegel N; Meir M; Spindler V; Germer CT; Waschke J
    J Cell Physiol; 2011 May; 226(5):1196-203. PubMed ID: 20945370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of CD146 as an ERM-binding protein offers novel mechanisms for melanoma cell migration.
    Luo Y; Zheng C; Zhang J; Lu D; Zhuang J; Xing S; Feng J; Yang D; Yan X
    Oncogene; 2012 Jan; 31(3):306-21. PubMed ID: 21725352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.